Sep 07, 2011
Augurix SA and Tillotts Pharma AG are pleased to announce that they have entered into a commercialization agreement for Simtomax®, a rapid point-of-care diagnostic test for celiac disease.
The agreement grants Tillotts the exclusive right to distribute and supply Simtomax® in dedicated key European markets.
Download full press release.
Also visit the website of Augurix.